GlassScriptPhysician profile
Kanika Govil
NPI 1215026703
$1,730.44
in general payments reported to CMS, 2019-2025
18 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $105 · 2021: $377 · 2022: $127 · 2023: $490 · 2024: $177 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $395.55 | 2019-2025 | Doc Band |
| Pfizer INC. | $382.77 | 2019-2024 | |
| Novo Nordisk INC | $236.76 | 2019-2025 | Wegovy |
| Glaxosmithkline, LLC. | $143.79 | 2019-2024 | Rotarix, Bexsero |
| Amgen INC. | $131.58 | 2021-2024 | Repatha, Otezla |
| Lilly USA, LLC | $69.46 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Exact Sciences Corporation | $67.47 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi Pasteur INC. | $59.04 | 2021-2023 | |
| Hologic Sales and Service, LLC | $47.98 | 2021 | |
| Astellas Pharma US INC | $42.07 | 2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $32.79 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $25.63 | 2024 | Rexulti |
| Coala Life INC | $24.30 | 2023 | Coala Heart Monitor |
| Corcept Therapeutics | $16.18 | 2019 | |
| Medtronic, INC. | $15.43 | 2025 | Inceptiv |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $14.84 | 2025 | Nuzyra |
| Neos Therapeutics, LP | $13.02 | 2020 | |
| Sobi, INC | $11.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kanika Govil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.